AVP and Central diabetes insipidus: As a result, the DBD patient can develop diabetes insipidus, which may lead to polyuria, hypovolemia, and elevated serum osmolarity [8]. Hormone replacement therapy (HRT) with arginine vasopressin (AVP) can treat diabetes insipidus and decrease serum osmolarity.